High-flow Conditioned Oxygen Therapy Versus Non-invasive Ventilation: Prevention of Post-extubation Failure

September 10, 2014 updated by: Gonzalo Hernandez Martinez, Hospital Infanta Sofia

Comparison Between High-flow Conditioned Oxygen Therapy and Non-invasive Ventilation in Prevention of Post-extubation Respiratory Failure. A Randomized Controlled Trial

The main aim is to demonstrate whether the high flow conditioned oxygen therapy reduces the reintubation rate. Post-extubation respiratory failure risk will be stratified (as the randomization). In high risk patients high flow conditioned oxygen therapy will be compared with with not conditioned non-invasive mechanical ventilation. In low risk patients comparison will be conventional oxygen therapy. Hypercapnic patients will be excluded.

Study Overview

Study Type

Interventional

Enrollment (Actual)

1042

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ciudad Real, Spain, 13005
        • Hospital General de Ciudad Real
    • Madrid
      • San Sebastian de los Reyes, Madrid, Spain, 28703
        • Hospital Infanta Sofía

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Low Risk Patients:
  • Any extubated patients after tolerating a spontaneous breathing trial.
  • High Risk Patients:
  • Any extubated patients after >48 hours under mechanical ventilation and any of the following:
  • >65 years

    • cardiac failure as the primary indication of mechanical ventilation
    • COPD
    • APACHE II >12 points the extubation day
    • BMI >30
    • inability to manage respiratory secretions

      • 1 failed spontaneous breathing trial
      • 1 comorbidity
      • 7 days under mechanical ventilation

Exclusion Criteria:

  • <18 years
  • thacheotomized patients
  • recent facial or cervical trauma/surgery
  • active gastro-intestinal bleeding
  • lack of cooperation and patients with any failed spontaneous breathing trial because of hypercapnia development.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Flow Conditioned Oxygen Therapy in high risk patients
OptiFlow system (R) with nasal cannula.
Active Comparator: Non-invasive mechanical ventilation in High Risk Patients
Bilevel pressure support through a facial mask
Experimental: High Flow Conditioned Oxygen Therapy in Low Risk Patients
OptiFlow system (R) with nasal cannula.
Active Comparator: Conventional Oxygen Therapy in Low Risk Patients
Conventional Oxygen Therapy with nasal cannula or Venturi facial mask.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Post-extubation respiratory failure and Reintubation rate
Time Frame: 3 months
3 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Hospital length of stay
Time Frame: 6 months
6 months
Intensive Care Unit length of stay
Time Frame: 3 months
3 months
Intensive Care Unit mortality rate
Time Frame: 3 month
3 month
Hospital mortality rate
Time Frame: 6 months
6 months
Nosocomial pneumonia rate
Time Frame: 3 months
3 months
Tracheobronchitis rate
Time Frame: 3 months
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Gonzalo Hernandez, MD, Hospital Infanta Sofía

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2012

Primary Completion (Actual)

September 1, 2014

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

August 27, 2010

First Submitted That Met QC Criteria

August 27, 2010

First Posted (Estimate)

August 30, 2010

Study Record Updates

Last Update Posted (Estimate)

September 12, 2014

Last Update Submitted That Met QC Criteria

September 10, 2014

Last Verified

September 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • HULP-3116

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-extubation Respiratory Failure

Clinical Trials on High Flow Conditioned Oxygen Therapy in High Risk Patients

Subscribe